3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
12
Spondylitis, Ankylosing
4
Psoriasis
2
Inflammatory Bowel Diseases
2
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammation
1
Infections
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Crohn Disease
1
Colitis, Ulcerative
1
Autoimmune Diseases
1
Arthritis, Psoriatic
1
Arthritis
1
Interventions
Nutrition Assessment
2
tocilizumab
1
methyl hydroxyethyl cellulose
1
acetaminophen, aspirin, caffeine drug combination
1
Walking
1
Vaccines
1
Transcutaneous Electric Nerve Stimulation
1
Saline Solution
1
Resistance Training
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Lysine Acetyltransferase 5
1
Injections, Intra-Articular
1
Infliximab
1
Immune Checkpoint Inhibitors
1
Holistic Health
1
Herpes Zoster Vaccine
1
Exergaming
1
Exercise Therapy
1
Etanercept
1
Cari-D-Tect
1
Blood Specimen Collection
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Anastrozole
1
Adalimumab
1
Abatacept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthritis
×
Adalimumab
×
Clear all
NCT00696059
2008-06-12
HURRAH
Hvidovre University Hospital
Phase 4
Completed
52 enrolled